Inmune Bio INMB
NASDAQ INMB
$1.93 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Inmune Bio (INMB) Accumulated Expenses (2022 - 2024)

Updated

Inmune Bio's Accumulated Expenses was $139,000 in Q2 2024, compared with $9,000 a year earlier and up 148.2% from the prior quarter.

Analysis

Inmune Bio (INMB) Accumulated Expenses (2022 - 2024) Analysis & Trends

At the end of FY2023, Accumulated Expenses at Inmune Bio came in at $35,000, up 288.9% from FY2022.

  • In earlier years, Accumulated Expenses was $9,000 in FY2022.
  • Per Business Quant data, INMB's Accumulated Expenses in the three quarters before Q2 2024 was $56,000 (Q1 2024), $35,000 (Q4 2023) and $79,000 (Q3 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Inmune Bio 53.92 Mn -38.33 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 139,000.00
Mar 31, 2024 56,000.00
Dec 31, 2023 35,000.00
Sep 30, 2023 79,000.00
Jun 30, 2023 9,000.00
Mar 31, 2023 9,000.00
Dec 31, 2022 9,000.00
API Access

Inmune Bio Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=INMB&period=max&api_key=YOUR_API_KEY